ReviewEuropean cardiology2026
Cardio-oncology, from Guidelines to Practice: Filling the Gap - an Eastern European Viewpoint.
Review in European cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Significant gaps persist in the real-world implementation of cardio-oncology guidelines, particularly in resource-limited settings. This viewpoint explores the application of evidence-based cardiovascular prevention, surveillance and management strategies amongst Romanian physicians treating cancer patients, enabling comparison with international data. A national, anonymous, online survey (September to November 2024) targeted cardiologists, oncologists, haematologists and internists. The 21-item questionnaire assessed institutional context, clinical practices, and adherence to international recommendations. A total of 190 responses were analysed. Centres with dedicated cardio-oncology teams and university affiliation more frequently apply structured risk stratification, monitor subclinical toxicity, and prescribe prophylactic pharmacotherapy. Centres without such teams demonstrate less consistent implementation of cardioprotective strategies and long-term follow-up. Cardiologists were more likely than oncologists to modify cancer therapy or initiate cardioprotective treatment in cases of early dysfunction. Long-term follow-up was inconsistently implemented and dependent on the institutional cardio-oncology organisation. Cardio-oncology practice in Romania remains heterogeneous, influenced by specialty, institutional resources and experience, highlighting the need for structured national programmes and interdisciplinary training.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.